BladeRanger to Showcase Advanced Green Energy Technologies at Abu Dhabi Sustainability Week
Stocks in this Quantisnow insightHealth Care
Historical context for PRFX
Across the 3 sessions after earlier PRFX headlines, the stock closed higher 3 times and lower 0 times, with a median move of 3.5% in either direction. This shows timing only: many things move a stock in a session, and these figures do not show that any headline caused a move.
| Session | Earlier headline | PRFX | SPY |
|---|---|---|---|
| Dec 10, 2025 | PainReform Confirms the Ability of Its LayerBio Drop-Less Sustained-Release Ocular Platform to Accommodate Multiple Drug Entities | +3.5% | +0.7% |
| Dec 2, 2025 | PainReform Commences Development for OcuRing™-K Phase II Trial, LayerBio's Drop-Less Sustained-Release Ocular Therapy | +2.3% | +0.2% |
| Nov 12, 2025 | PainReform's DeepSolar Advances Development of its AI-Driven Automated Reporting Engine for Solar-Asset Analysis | +9.2% | +0.1% |
Quantisnow market dataNASDAQ
PRFX
PRF Technologies Ltd.
- Market cap
- 30-day
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- Listed since
- 2020
Get push alerts for PRFX
Full PRFX profile on Quantisnow Follow PRFX and get a push notification the moment its next story breaks.